{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:52:05Z","timestamp":1792792325641,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No. 81901667"],"award-info":[{"award-number":["Grant No. 81901667"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No. 82071841"],"award-info":[{"award-number":["Grant No. 82071841"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"2019 Discipline Development Project of Peking Union Medical College","award":["Grant No. 201920200106"],"award-info":[{"award-number":["Grant No. 201920200106"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-044"],"award-info":[{"award-number":["2022-PUMCH-B-044"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fibromyalgia (FM) is a multifaceted disease. Along with the genetic, environmental and neuro-hormonal factors, inflammation has been assumed to have role in the pathogenesis of FM. The aim of the present study was to explore the differences in clinical features and pathophysiology of FM patients under different inflammatory status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The peripheral blood gene expression profile of FM patients in the Gene Expression Omnibus database was downloaded. Differentially expressed inflammatory genes were identified, and two molecular subtypes were constructed according to these genes used unsupervised clustering analysis. The clinical characteristics, immune features and pathways activities were compared further between the two subtypes. Then machine learning was used to perform the feature selection and construct a classification model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The patients with FM were divided into micro-inflammation and non-inflammation subtypes according to 54 differentially expressed inflammatory genes. The micro-inflammation group was characterized by more major depression (<jats:italic>p<\/jats:italic>\u2009=\u20090.049), higher BMI (<jats:italic>p<\/jats:italic>\u2009=\u20090.021), more active dendritic cells (<jats:italic>p<\/jats:italic>\u2009=\u20090.010) and neutrophils. Functional enrichment analysis showed that innate immune response and antibacterial response were significantly enriched in micro-inflammation subtype (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.050). Then 5 hub genes (<jats:italic>MMP8<\/jats:italic>, <jats:italic>ENPP3<\/jats:italic>, <jats:italic>MAP2K3<\/jats:italic>, <jats:italic>HGF<\/jats:italic>, <jats:italic>YES1<\/jats:italic>) were screened thought three feature selection algorithms, an accurate classifier based on the 5 hub DEIGs and 2 clinical parameters were constructed using support vector machine model. Model scoring indicators such as AUC (0.945), accuracy (0.936), F1 score (0.941), Brier score (0.079) and Hosmer\u2013Lemeshow goodness-of-fit test (\u03c7<jats:sup>2<\/jats:sup>\u2009=\u20094.274, <jats:italic>p<\/jats:italic>\u2009=\u20090.832) proved that this SVM-based classifier was highly reliable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Micro-inflammation status in FM was significantly associated with the occurrence of depression and activated innate immune response. Our study calls attention to the pathogenesis of different subtypes of FM.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-04477-w","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T11:02:24Z","timestamp":1693911744000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Micro-inflammation related gene signatures are associated with clinical features and immune status of fibromyalgia"],"prefix":"10.1186","volume":"21","author":[{"given":"Menghui","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingdong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"issue":"6","key":"4477_CR1","first-page":"1065","volume":"40","author":"V Giorgi","year":"2022","unstructured":"Giorgi V, Sirotti S, Romano ME, et al. Fibromyalgia: one year in review 2022. Clin Exp Rheumatol. 2022;40(6):1065\u201372.","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"4477_CR2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","volume":"16","author":"P Sarzi-Puttini","year":"2020","unstructured":"Sarzi-Puttini P, Giorgi V, Marotto D, et al. Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol. 2020;16(11):645\u201360.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"4477_CR3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","volume":"17","author":"LP Queiroz","year":"2013","unstructured":"Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356.","journal-title":"Curr Pain Headache Rep"},{"key":"4477_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083891","author":"R Siracusa","year":"2021","unstructured":"Siracusa R, Paola RD, Cuzzocrea S, et al. Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22083891.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4477_CR5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/1573397112666160919120530","volume":"13","author":"S Metyas","year":"2017","unstructured":"Metyas S, Rezk T, Arkfeld D, et al. Autoinflammation and immunomodulation in inflammatory fibromyalgia syndrome\u2014a review. Curr Rheumatol Rev. 2017;13(2):98\u2013102.","journal-title":"Curr Rheumatol Rev"},{"issue":"1","key":"4477_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/138161206775193208","volume":"12","author":"DJ Wallace","year":"2006","unstructured":"Wallace DJ. Is there a role for cytokine based therapies in fibromyalgia. Curr Pharm Des. 2006;12(1):17\u201322.","journal-title":"Curr Pharm Des"},{"issue":"1\u20132","key":"4477_CR7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jneuroim.2011.10.013","volume":"242","author":"D Kadetoff","year":"2012","unstructured":"Kadetoff D, Lampa J, Westman M, et al. Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels. J Neuroimmunol. 2012;242(1\u20132):33\u20138.","journal-title":"J Neuroimmunol"},{"key":"4477_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jneuroim.2015.11.011","volume":"290","author":"D Mendieta","year":"2016","unstructured":"Mendieta D, De La Cruz-Aguilera DL, Barrera-Villalpando MI, et al. IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients. J Neuroimmunol. 2016;290:22\u20135.","journal-title":"J Neuroimmunol"},{"issue":"6","key":"4477_CR9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000341664","volume":"19","author":"ME Bote","year":"2012","unstructured":"Bote ME, Garc\u00eda JJ, Hinchado MD, et al. Inflammatory\/stress feedback dysregulation in women with fibromyalgia. NeuroImmunoModulation. 2012;19(6):343\u201351.","journal-title":"NeuroImmunoModulation"},{"key":"4477_CR10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2016.05.011","volume":"84","author":"A Ranzolin","year":"2016","unstructured":"Ranzolin A, Duarte AL, Bredemeier M, et al. Evaluation of cytokines, oxidative stress markers and brain-derived neurotrophic factor in patients with fibromyalgia\u2014a controlled cross-sectional study. Cytokine. 2016;84:25\u20138.","journal-title":"Cytokine"},{"key":"4477_CR11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/JPR.S128508","volume":"10","author":"E B\u00e4ckryd","year":"2017","unstructured":"B\u00e4ckryd E, Tanum L, Lind AL, et al. Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma. J Pain Res. 2017;10:515\u201325.","journal-title":"J Pain Res"},{"issue":"2","key":"4477_CR12","first-page":"195","volume":"32","author":"F Mastrangelo","year":"2018","unstructured":"Mastrangelo F, Frydas I, Ronconi G, et al. Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37. J Biol Regul Homeost Agents. 2018;32(2):195\u20138.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"2","key":"4477_CR13","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s12035-014-9055-4","volume":"53","author":"NS Gregory","year":"2016","unstructured":"Gregory NS, Brito RG, Fusaro M, et al. ASIC3 is required for development of fatigue-induced hyperalgesia. Mol Neurobiol. 2016;53(2):1020\u201330.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"4477_CR14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.outlook.2013.03.007","volume":"61","author":"N Lukkahatai","year":"2013","unstructured":"Lukkahatai N, Majors B, Reddy S, et al. Gene expression profiles of fatigued fibromyalgia patients with different categories of pain and catastrophizing: a preliminary report. Nurs Outlook. 2013;61(4):216-224.e2.","journal-title":"Nurs Outlook"},{"issue":"2 Suppl 96","key":"4477_CR15","first-page":"S89","volume":"34","author":"KD Jones","year":"2016","unstructured":"Jones KD, Gelbart T, Whisenant TC, et al. Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia. Clin Exp Rheumatol. 2016;34(2 Suppl 96):S89-98.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"4477_CR16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s41232-022-00215-9","volume":"42","author":"W Lin","year":"2022","unstructured":"Lin W, Gao J, Zhang H, et al. Identification of molecular subtypes based on inflammatory response in lower-grade glioma. Inflamm Regen. 2022;42(1):29.","journal-title":"Inflamm Regen"},{"issue":"1","key":"4477_CR17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248\u201362.","journal-title":"Cell Rep"},{"key":"4477_CR18","volume":"11","author":"M Yao","year":"2020","unstructured":"Yao M, Gao C, Zhang C, et al. Identification of molecular markers associated with the pathophysiology and treatment of lupus nephritis based on integrated transcriptome analysis. Front Genet. 2020;11: 583629.","journal-title":"Front Genet"},{"key":"4477_CR19","volume":"13","author":"J He","year":"2022","unstructured":"He J, Li X. Identification and validation of aging-related genes in idiopathic pulmonary fibrosis. Front Genet. 2022;13: 780010.","journal-title":"Front Genet"},{"key":"4477_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194976","author":"G Karami","year":"2021","unstructured":"Karami G, Giuseppe Orlando M, Delli Pizzi A, et al. Predicting overall survival time in glioblastoma patients using gradient boosting machines algorithm and recursive feature elimination technique. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13194976.","journal-title":"Cancers (Basel)"},{"key":"4477_CR21","volume":"10","author":"X Song","year":"2022","unstructured":"Song X, Zhu J, Tan X, et al. XGBoost-based feature learning method for mining COVID-19 novel diagnostic markers. Front Public Health. 2022;10: 926069.","journal-title":"Front Public Health"},{"issue":"3","key":"4477_CR22","first-page":"273","volume":"20","author":"C Cortes","year":"1995","unstructured":"Cortes C, Vapnik V. Support-vector networks. Mach Learn. 1995;20(3):273\u201397.","journal-title":"Mach Learn"},{"issue":"1","key":"4477_CR23","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1186\/s12885-021-08647-1","volume":"21","author":"MX Li","year":"2021","unstructured":"Li MX, Sun XM, Cheng WG, et al. Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma. BMC Cancer. 2021;21(1):906.","journal-title":"BMC Cancer"},{"issue":"12","key":"4477_CR24","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/cam4.4617","volume":"11","author":"W Liu","year":"2022","unstructured":"Liu W, Wang S, Ye Z, et al. Prediction of lung metastases in thyroid cancer using machine learning based on SEER database. Cancer Med. 2022;11(12):2503\u201315.","journal-title":"Cancer Med"},{"issue":"2","key":"4477_CR25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/sim.4780030207","volume":"3","author":"FE Harrell, Jr.","year":"1984","unstructured":"Harrell, Jr. FE, Lee KL, Califf RM, et al. Regression modelling strategies for improved prognostic prediction. Stat Med. 1984;3(2):143\u201352.","journal-title":"Stat Med"},{"issue":"5","key":"4477_CR26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00296-019-04251-6","volume":"39","author":"BI Coskun","year":"2019","unstructured":"Coskun BI. Role of inflammation in the pathogenesis and treatment of fibromyalgia. Rheumatol Int. 2019;39(5):781\u201391.","journal-title":"Rheumatol Int"},{"key":"4477_CR27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jneuroim.2017.12.007","volume":"316","author":"A Andrade","year":"2018","unstructured":"Andrade A, Vilarino GT, Sieczkowska SM, et al. Acute effects of physical exercises on the inflammatory markers of patients with fibromyalgia syndrome: a systematic review. J Neuroimmunol. 2018;316:40\u20139.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"4477_CR28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.12968\/hmed.2012.73.4.211","volume":"73","author":"FJ Dunne","year":"2012","unstructured":"Dunne FJ, Dunne CA. Fibromyalgia syndrome and depression: common pathways. Br J Hosp Med (Lond). 2012;73(4):211\u20137.","journal-title":"Br J Hosp Med (Lond)"},{"issue":"5","key":"4477_CR29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11916-007-0214-4","volume":"11","author":"D Buskila","year":"2007","unstructured":"Buskila D, Cohen H. Comorbidity of fibromyalgia and psychiatric disorders. Curr Pain Headache Rep. 2007;11(5):333\u20138.","journal-title":"Curr Pain Headache Rep"},{"issue":"4","key":"4477_CR30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4081\/reumatismo.2012.268","volume":"64","author":"A Alciati","year":"2012","unstructured":"Alciati A, Sgiarovello P, Atzeni F, et al. Psychiatric problems in fibromyalgia: clinical and neurobiological links between mood disorders and fibromyalgia. Reumatismo. 2012;64(4):268\u201374.","journal-title":"Reumatismo"},{"key":"4477_CR31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","volume":"87","author":"EF Osimo","year":"2020","unstructured":"Osimo EF, Pillinger T, Rodriguez IM, et al. Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls. Brain Behav Immun. 2020;87:901\u20139.","journal-title":"Brain Behav Immun"},{"key":"4477_CR32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.psyneuen.2018.05.026","volume":"95","author":"E Haroon","year":"2018","unstructured":"Haroon E, Daguanno AW, Woolwine BJ, et al. Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder. Psychoneuroendocrinology. 2018;95:43\u20139.","journal-title":"Psychoneuroendocrinology"},{"issue":"12","key":"4477_CR33","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1038\/s41380-021-01272-1","volume":"26","author":"MG Kitzbichler","year":"2021","unstructured":"Kitzbichler MG, Aruldass AR, Barker GJ, et al. Peripheral inflammation is associated with micro-structural and functional connectivity changes in depression-related brain networks. Mol Psychiatry. 2021;26(12):7346\u201354.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"4477_CR34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41398-022-02297-y","volume":"13","author":"B Guo","year":"2023","unstructured":"Guo B, Zhang M, Hao W, et al. Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression. Transl Psychiatry. 2023;13(1):5.","journal-title":"Transl Psychiatry"},{"issue":"12","key":"4477_CR35","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s10067-008-0966-1","volume":"27","author":"L Neumann","year":"2008","unstructured":"Neumann L, Lerner E, Glazer Y, et al. A cross-sectional study of the relationship between body mass index and clinical characteristics, tenderness measures, quality of life, and physical functioning in fibromyalgia patients. Clin Rheumatol. 2008;27(12):1543\u20137.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"4477_CR36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/030097402317255336","volume":"31","author":"MB Yunus","year":"2002","unstructured":"Yunus MB, Arslan S, Aldag JC. Relationship between body mass index and fibromyalgia features. Scand J Rheumatol. 2002;31(1):27\u201331.","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"4477_CR37","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00296-012-2538-6","volume":"33","author":"Y Xiao","year":"2013","unstructured":"Xiao Y, Haynes WL, Michalek JE, et al. Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate. Rheumatol Int. 2013;33(5):1259\u201364.","journal-title":"Rheumatol Int"},{"issue":"2","key":"4477_CR38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00281-016-0583-z","volume":"39","author":"A Waisman","year":"2017","unstructured":"Waisman A, Lukas D, Clausen BE, et al. Dendritic cells as gatekeepers of tolerance. Semin Immunopathol. 2017;39(2):153\u201363.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"4477_CR39","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s10020-022-00431-6","volume":"28","author":"L Zhao","year":"2022","unstructured":"Zhao L, Li Y, Xu T, et al. Dendritic cell-mediated chronic low-grade inflammation is regulated by the RAGE-TLR4-PKC\u03b2(1) signaling pathway in diabetic atherosclerosis. Mol Med. 2022;28(1):4.","journal-title":"Mol Med"},{"issue":"1","key":"4477_CR40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.gastro.2005.05.013","volume":"129","author":"AL Hart","year":"2005","unstructured":"Hart AL, Al-Hassi HO, Rigby RJ, et al. Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology. 2005;129(1):50\u201365.","journal-title":"Gastroenterology"},{"key":"4477_CR41","volume":"13","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Shi W, Zhao D, et al. Identification of immune-associated genes in diagnosing aortic valve calcification with metabolic syndrome by integrated bioinformatics analysis and machine learning. Front Immunol. 2022;13: 937886.","journal-title":"Front Immunol"},{"key":"4477_CR42","doi-asserted-by":"crossref","first-page":"963689720969176","DOI":"10.1177\/0963689720969176","volume":"30","author":"M Tian","year":"2021","unstructured":"Tian M, Wang T, Wang P. Development and clinical validation of a seven-gene prognostic signature based on multiple machine learning algorithms in kidney cancer. Cell Transplant. 2021;30:963689720969176.","journal-title":"Cell Transplant"},{"key":"4477_CR43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.13187\/mai.2015.6.171","volume":"2","author":"H Vural","year":"2015","unstructured":"Vural H, Suba\u015f\u0131 A. Data-mining techniques to classify microarray gene expression data using gene selection by SVD and information gain. Model Artif Intell. 2015;2:171\u201382.","journal-title":"Model Artif Intell"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04477-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04477-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04477-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T16:32:46Z","timestamp":1700325166000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04477-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4477"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04477-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"assertion":[{"value":"11 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"594"}}